Learn More
Selleck Chemical LLC Bavdegalutamide (ARV-110) | 98.78% | 2222112-77-6 | 25mg

Supplier: Selleck Chemical LLC S696525MG
Bavdegalutamide (ARV-110), an orally bioavailable, specific androgen receptor (AR) PROTAC degrader that leads to ubiquitination and degradation of AR. ARV-110 completely degrades androgen receptor (AR) in all cell lines tested with DC50 of < 1 nM. ARV-110 can be used for the research of prostate cancer.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.